• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

Chemical Profile of 4-4-(benzyloxy)phenylpyridine (CAS No: 627906-66-5)

4-4-(benzyloxy)phenylpyridine, identified by its Chemical Abstracts Service (CAS) number 627906-66-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the pyridine class of heterocyclic aromatic compounds, characterized by a six-membered ring containing one nitrogen atom. The presence of a benzyloxy substituent at the para position relative to the pyridine ring introduces unique electronic and steric properties, making it a versatile scaffold for drug discovery and development.

The structural motif of 4-4-(benzyloxy)phenylpyridine combines the bioisosteric potential of phenyl and pyridine rings with the electron-donating nature of the benzyloxy group. This configuration enhances its interaction with biological targets, particularly enzymes and receptors, by modulating both hydrophobicity and hydrogen bonding capabilities. Such features are highly valuable in designing molecules with improved pharmacokinetic profiles and reduced off-target effects.

In recent years, there has been a surge in research focusing on pyridine derivatives due to their broad spectrum of biological activities. Pyridine-based compounds have been extensively explored for their roles in central nervous system (CNS) disorders, cardiovascular diseases, and oncology. The introduction of the benzyloxy group in 4-4-(benzyloxy)phenylpyridine further expands its therapeutic potential by enhancing solubility and metabolic stability, which are critical factors for drug efficacy and safety.

One of the most compelling aspects of 4-4-(benzyloxy)phenylpyridine is its utility as a building block in medicinal chemistry. Researchers have leveraged this scaffold to develop novel inhibitors targeting key enzymes involved in disease pathways. For instance, studies have demonstrated its applicability in modulating kinases, which are aberrantly expressed in various cancers. The benzyloxy moiety serves as an effective linker, improving binding affinity while maintaining structural flexibility necessary for enzyme interaction.

Advances in computational chemistry have further accelerated the exploration of 4-4-(benzyloxy)phenylpyridine derivatives. Molecular docking simulations and virtual screening have identified promising analogs with enhanced potency against therapeutic targets. These computational approaches complement experimental efforts, enabling rapid optimization of lead compounds before moving into costly and time-consuming synthetic rounds.

The pharmacological profile of 4-4-(benzyloxy)phenylpyridine has been investigated through both in vitro and in vivo studies. Initial assays have revealed notable interactions with proteins such as G protein-coupled receptors (GPCRs) and ion channels, suggesting potential applications in treating neurological disorders. Additionally, preclinical trials have hinted at its efficacy in reducing inflammation by inhibiting pro-inflammatory cytokine production.

The synthesis of 4-4-(benzyloxy)phenylpyridine involves multi-step organic transformations that highlight the ingenuity of modern synthetic methodologies. Key steps include palladium-catalyzed cross-coupling reactions to establish the phenyl-pyridine connection, followed by nucleophilic substitution to introduce the benzyloxy group. These reactions are optimized for high yield and selectivity, ensuring scalability for industrial applications.

In conclusion, 4-4-(benzyloxy)phenylpyridine (CAS No: 627906-66-5) represents a significant advancement in pharmaceutical chemistry. Its unique structural features offer a rich foundation for developing next-generation therapeutics targeting diverse diseases. As research continues to uncover new biological functions and synthetic strategies, this compound is poised to play an increasingly pivotal role in drug discovery initiatives worldwide.

• 49826-70-2(4-(Benzyloxy)pyridine)
• 61672-52-4(Isoquinoline, 5-(phenylmethoxy)-)
• 1261910-34-2(5-(4-Benzyloxyphenyl)-3-hydroxypyridine)
• 1258608-97-7(3-Pyridinol, 5-[3-(phenylmethoxy)phenyl]-)
• 76509-17-6(3-(benzyloxy)pyridine)
• 929917-95-3(3-(4-(Benzyloxy)phenyl)pyridine)
• 158984-80-6(7-(Benzyloxy)isoquinoline)
• 642084-39-7(Pyridine, 3,3'-[1,3-phenylenebis(methyleneoxy)]bis-)
• 106047-20-5(Pyridine, 4-[2-(phenylmethoxy)phenyl]-)
• 4357-31-7(4-(4-Ethoxyphenyl)pyridine)